When compared to the PBS treatment, 2 μg IL-15 showed no tumor inhibition, while P22339 at 5 μg and 15 μg doses exhibited 30% and 46% antitumor activity respectively on day 4 after treatment. Here, IL15 is linked to neoplasm.